Trademark: 97577037
Word
LITJURN
Status
Registered
Status Code
700
Status Date
Tuesday, October 10, 2023
Serial Number
97577037
Registration Number
7188697
Registration Date
Tuesday, October 10, 2023
Mark Type
4000
Filing Date
Friday, September 2, 2022
Published for Opposition
Tuesday, July 25, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Oct 10, 2023
Notice Of Registration Confirmation Emailed
Oct 10, 2023
Registered-Principal Register
Jul 25, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2023
Published For Opposition
Jul 5, 2023
Notification Of Notice Of Publication E-Mailed
Jun 21, 2023
Approved For Pub - Principal Register
Jun 19, 2023
Assigned To Examiner
Sep 21, 2022
New Application Office Supplied Data Entered
Sep 6, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24